Marc Learned
Chief Tech/Sci/R&D Officer presso NGM BIOPHARMACEUTICALS, INC.
Profilo
Currently, Marc Learned holds the position of Vice President-Research Operations at NGM Biopharmaceuticals, Inc.
In the past he was Research Director-Metabolic Disorders at Amgen, Inc. and Associate Director at Tularik, Inc. (a subsidiary of Amgen, Inc.) and Assistant Professor at the University of California, Davis.
Dr. Learned received an undergraduate degree from the University of California, Los Angeles and an undergraduate degree and a doctorate from the University of California, Berkeley.
Posizioni attive di Marc Learned
Società | Posizione | Inizio |
---|---|---|
NGM BIOPHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 18/08/2009 |
Precedenti posizioni note di Marc Learned
Società | Posizione | Fine |
---|---|---|
Tularik, Inc.
Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - |
University of California, Davis | Corporate Officer/Principal | - |
AMGEN INC. | Corporate Officer/Principal | - |
Formazione di Marc Learned
University of California, Los Angeles | Undergraduate Degree |
University of California, Berkeley | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
AMGEN INC. | Health Technology |
NGM BIOPHARMACEUTICALS, INC. | Health Technology |
Aziende private | 1 |
---|---|
Tularik, Inc.
Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | Commercial Services |